The fight against the COVID-19 pandemic has highlighted the need and urgency for Europe to have rapid reaction mechanisms in place to protect its citizens. The 2019 coronavirus has highlighted the discrepancies in assessments between the 27 countries, both of the threat to health and of the measures to be taken to help citizens.
Today’s EU pharmaceutical market is unsustainable, due to the fragmentation of EU players and public dependence on private interests. A recent Panel for the Future of Science and Technology (STOA) study of the EP proposes a solution involving the creation of a public European medicines infrastructure, a body that would control of the entire
The coronavirus pandemic has hit the tourism sector hard. The impact on various tourist destinations in the EU has been asymmetrical and highly … Re-starting tourism in the EU amid the pandemic
During the February Plenary Session, the European Parliament will debate five topics regarding COVID-19. One concerns the EU’s mega aid plan for countries in difficulty: the Recovery and Resilience Fund of € 750 billion. What will be the vote of the sovereign parties of the right and the extreme left? The question is legitimate